High-dose influenza vaccines make economic sense for older people

Lancet Infect Dis. 2015 Dec;15(12):1372-3. doi: 10.1016/S1473-3099(15)00272-8. Epub 2015 Sep 8.

Author

Mark Jit¹

Affiliation

¹ Modelling and Economics Unit, Public Health England, London NW9 5EQ, UK; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK. Electronic address: mark.jit@phe.gov.uk.

PMID: 26362173
DOI: 10.1016/S1473-3099(15)00272-8

No abstract available

Publication types

Comment

MeSH terms

Cost-Benefit Analysis*
Female
Humans
Influenza A virus / immunology*
Influenza Vaccines / economics*
Influenza, Human / economics*
Male
Models, Statistical*

Substances

Influenza Vaccines